Skip to content
Recall Observatory FDA recall evidence

Drug product

Revonto (dantrolene sodium for injection), 20 mg/vial, For treatment of malignant hyperthermia, For Intravenous Use Only, Rx Only, Made in Italy, Dist. by: US WorldMeds, LLC, Louisville, KY 40241, NDC: 27505-003-67

D-1275-2019

April 25, 2019

Class II

Product summary

Firm
US Worldmeds LLC
Event
Event 82660
Status
Terminated
Classification
Class II
Quantity
6456 vials
Official record key
drug-enforcement:D-1275-2019

Official wording

Reason: Presence of Precipitate: Appearance is Out of Specification for the reconstituted solution during 24-month stability time point analysis.

Code information: Lot: 17REV01, Exp. 12/2019

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of Specification